ALBI, ELISA
 Distribuzione geografica
Continente #
NA - Nord America 193
EU - Europa 125
AS - Asia 42
Continente sconosciuto - Info sul continente non disponibili 1
Totale 361
Nazione #
US - Stati Uniti d'America 192
IT - Italia 52
IE - Irlanda 35
SG - Singapore 16
HK - Hong Kong 12
CN - Cina 10
RO - Romania 7
FI - Finlandia 6
RU - Federazione Russa 6
DE - Germania 5
UA - Ucraina 4
SE - Svezia 3
AT - Austria 2
CZ - Repubblica Ceca 2
IN - India 2
CH - Svizzera 1
EU - Europa 1
FR - Francia 1
KR - Corea 1
MX - Messico 1
PL - Polonia 1
UZ - Uzbekistan 1
Totale 361
Città #
Chandler 54
Dublin 35
Perugia 35
San Mateo 24
Singapore 15
Hong Kong 12
Wilmington 10
Andover 8
Boardman 8
Altamura 7
Bucharest 7
Medford 7
Santa Clara 7
Helsinki 6
Princeton 6
Beijing 5
Falls Church 5
Lawrence 5
Dearborn 3
Ashburn 2
Bengaluru 2
Brno 2
Foligno 2
New York 2
Vienna 2
Civitanova Marche 1
Frankfurt Am Main 1
Fremont 1
Jinan 1
Los Angeles 1
Mexico City 1
Moscow 1
Munich 1
Norwalk 1
Redmond 1
Seoul 1
Totale 282
Nome #
NOTCH1 Aberrations in Chronic Lymphocytic Leukemia. 71
Decreased NOTCH1 Activation Correlates with Response to Ibrutinib in Chronic Lymphocytic Leukemia 71
NOTCH1 Is Aberrantly Activated in Chronic Lymphocytic Leukemia Hematopoietic Stem Cells. 70
Ibrutinib treatment of a patient with relapsing chronic lymphocytic leukemia and sustained remission of Richter syndrome 62
Cytogenetic/mutation profile of chronic lymphocytic leukemia/malignant melanoma collision tumors of the skin 52
null 37
NOTCH1 Aberrant Activation Is a Common Nonmutational Early Event in Chronic Lymphocytic Leukemia Hematopoietic Stem-Cells 28
Totale 391
Categoria #
all - tutte 1.668
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.668


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202031 0 0 0 0 0 0 3 2 6 19 1 0
2020/202114 0 0 0 0 14 0 0 0 0 0 0 0
2021/202290 0 23 1 0 4 3 2 21 2 9 12 13
2022/2023130 6 24 0 16 14 9 0 8 50 0 2 1
2023/202450 5 7 7 0 2 2 14 0 0 1 5 7
2024/202531 4 7 5 2 10 3 0 0 0 0 0 0
Totale 391